These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 10565879

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical aspects of anticholinergic agents].
    Friedman M.
    Rev Mal Respir; 1998 Sep; 15 Suppl 2():S51-4. PubMed ID: 9809345
    [No Abstract] [Full Text] [Related]

  • 3. Anticholinergic agents in asthma and COPD.
    Gross NJ.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):36-9. PubMed ID: 16488410
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical aspects of inhaled anticholinergic therapy.
    Campbell SC.
    Respir Care; 2000 Jul 08; 45(7):864-7. PubMed ID: 10926384
    [Abstract] [Full Text] [Related]

  • 6. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
    Breekveldt-Postma NS, Koerselman J, Erkens JA, Lammers JW, Herings RM.
    Respir Med; 2007 Jul 08; 101(7):1398-405. PubMed ID: 17368011
    [Abstract] [Full Text] [Related]

  • 7. Tiotropium: a potential replacement for ipratropium in patients with COPD.
    Shukla VK.
    Issues Emerg Health Technol; 2002 Jul 08; (35):1-4. PubMed ID: 12195603
    [Abstract] [Full Text] [Related]

  • 8. Tiotropium: a bronchodilator for chronic obstructive pulmonary disease.
    Somand H, Remington TL.
    Ann Pharmacother; 2005 Sep 08; 39(9):1467-75. PubMed ID: 16030078
    [Abstract] [Full Text] [Related]

  • 9. The short, the long and the "ultra-long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease.
    Beeh KM, Beier J.
    Adv Ther; 2010 Mar 08; 27(3):150-9. PubMed ID: 20411368
    [Abstract] [Full Text] [Related]

  • 10. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
    Ikeda A, Nishimura K, Izumi T.
    Chest; 1996 Jan 08; 109(1):294. PubMed ID: 8549208
    [No Abstract] [Full Text] [Related]

  • 11. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC, Little KS, Laughlin KR, Galbraith JM, Gustman PM, Murphy D, Kram JA, Hardie G, Reuter C, Ostransky D, McFarland K, Petty TL, Silvers W, Rennard SI, Mueller M, Repsher LH, Zuwallack RL, Vale R.
    Am J Med; 1996 Jan 29; 100(1A):40S-48S. PubMed ID: 8610716
    [Abstract] [Full Text] [Related]

  • 12. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
    Ingram RH.
    Chest; 1996 Jan 29; 109(1):293. PubMed ID: 8549206
    [No Abstract] [Full Text] [Related]

  • 13. [Tiotropium (Spiriva) - a long-acting inhaled anticholinergic for the treatment of chronic obstructive pulmonary disease (COPD)].
    Beeh KM, Welte T, Buhl R.
    Pneumologie; 2003 Sep 29; 57(9):519-25. PubMed ID: 13680472
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease.
    Colice GL.
    Am J Med; 1996 Jan 29; 100(1A):11S-18S. PubMed ID: 8610712
    [Abstract] [Full Text] [Related]

  • 16. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients.
    Pillet O, Manier G, Castaing Y.
    Monaldi Arch Chest Dis; 1998 Feb 29; 53(1):3-8. PubMed ID: 9632900
    [Abstract] [Full Text] [Related]

  • 17. [Milestones in inhalation therapy of airway diseases].
    Wettengel R.
    Med Klin (Munich); 2002 Dec 15; 97 Suppl 2():7-11. PubMed ID: 12593175
    [Abstract] [Full Text] [Related]

  • 18. Tiotropium: a new, long-acting agent for the management of COPD--a clinical review.
    Crutchfield D.
    Director; 2004 Dec 15; 12(3):160, 162-4. PubMed ID: 15323298
    [Abstract] [Full Text] [Related]

  • 19. Combined bronchodilator therapy in the management of chronic obstructive pulmonary disease.
    Friedman M.
    Respirology; 1997 Dec 15; 2 Suppl 1():S19-23. PubMed ID: 9400691
    [Abstract] [Full Text] [Related]

  • 20. A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence.
    Easton PA, Jadue C, Dhingra S, Anthonisen NR.
    N Engl J Med; 1986 Sep 18; 315(12):735-9. PubMed ID: 2943994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.